Documents

EBITDA surged 39% year-over-year, with strong margins and strategic ammonia acquisition boosting outlook.

$1.3B Texas ammonia plant acquisition boosts capacity, cost efficiency, and strategic flexibility.

Market volatility, plant outages, and cost reductions shape 2Q 2026 outlook; results due July 17.

EBITDA surged 40% year-over-year as strong execution offset global market disruptions.

Strong early demand, urea price surge, and updated CBAM sensitivities shape 1Q26 outlook.

EBITDA to rise by $350M by 2030 through efficiency, decarbonization, and premium growth.

Q4 saw strong European sales from pre-CBAM buying, with tight global nitrogen markets and higher 2026 CapEx.

EBITDA up 37% and EPS quadrupled, with strong cash flow and a NOK 22/share dividend proposed.

Expanded margins and stable demand drive Q3, with focus on U.S. ammonia and regulatory shifts.

EBITDA up 38% year-over-year, with record ROIC and cost reductions ahead of plan.

High urea prices, tight phosphate markets, and slowing supply growth challenge fertilizer affordability.

European market share gains, asset optimization, and strong NPK margins drive performance.

EBITDA rose 27% year-over-year, with cost cuts and strong margins driving higher returns.